EligoChem
Sandwich
About EligoChem
EligoChem has developed a proprietary and patentable technology that facilitates the design of highly water-soluble drugs that are absorbed well by the human body. One in fifteen known drug compounds have this combination of properties, but they are present in only one in ten thousand compounds in current pharma screening collections. This technology is particularly suited to antibiotic drug discovery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.8M
- Funding stage: Seed
- Last round: Grant (Aug 2017)
- Website: eligochem.com
- Phone: +44 (0)1304 806392
Industries & Categories
App Discovery, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/eligochem-109240 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.